EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers

Devan Diwanji, Emmanuel Carrodeguas, Youngho Seo, Hyunseok Kang iD, Myat Han Soe, Janet M Chiang, Li Zhang iD, Chienying Liu iD, Spencer C Behr iD, Robert R Flavell iD

Journal of Clinical Medicine · 06.07.2024 · 13 (13) · 3963

DOI: 10.3390/jcm13133963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.07.2024. Verfasst von Devan Diwanji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health and National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metastatic differentiated thyroid cancer (DTC) represents a molecularly heterogeneous group of cancers with varying radioactive iodine (RAI) and [18F]-fluorodeoxyglucose (FDG) uptake patterns potentially correlated with the degree of de-differentiation through the so-called “flip-flop” phenomenon. However, it is unknown if RAI and FDG uptake patterns correlate with molecular status or metastatic site. Materials and Methods: A retrospective analysis of metastatic DTC patients (n = 46) with radioactive 131-iodine whole body scan (WBS) and FDG-PET imaging between 2008 and 2022 was performed. The inclusion criteria included accessible FDG-PET and WBS studies within 1 year of each other. Studies were interpreted by two blinded radiologists for iodine or FDG uptake in extrathyroidal sites including lungs, lymph nodes, and bone. Cases were stratified by BRAF V600E mutation status, histology, and a combination of tumor genotype and histology. The data were analyzed by McNemar’s Chi-square test.

Results

Lung metastasis FDG uptake was significantly more common than iodine uptake (WBS: 52%, FDG: 84%, p = 0.04), but no significant differences were found for lymph or bone metastases. Lung metastasis FDG uptake was significantly more prevalent in the papillary pattern sub-cohort (WBS: 37%, FDG: 89%, p = 0.02) than the follicular pattern sub-cohort (WBS: 75%, FDG: 75%, p = 1.00). Similarly, BRAF V600E+ tumors with lung metastases also demonstrated a preponderance of FDG uptake (WBS: 29%, FDG: 93%, p = 0.02) than BRAF V600E− tumors (WBS: 83%, FDG: 83%, p = 1.00) with lung metastases. Papillary histology featured higher FDG uptake in lung metastasis (WBS: 39%, FDG: 89%, p = 0.03) compared with follicular histology (WBS: 69%, FDG: 77%, p = 1.00). Patients with papillary pattern disease, BRAF V600E+ mutation, or papillary histology had reduced agreement between both modalities in uptake at all metastatic sites compared with those with follicular pattern disease, BRAF V600E− mutation, or follicular histology. Low agreement in lymph node uptake was observed in all patients irrespective of molecular status or histology.

Conclusions

The pattern of FDG-PET and radioiodine uptake is dependent on molecular status and metastatic site, with those with papillary histology or BRAF V600E+ mutation featuring increased FDG uptake in distant metastasis. Further study with an expanded cohort may identify which patients may benefit from specific imaging modalities to recognize and surveil metastases.

Schlagwörter

Stichwörter der Autor:innen

Iodine-131PETPET/CTRAIdifferentiated thyroid cancerpositron emission tomographythyroid cancer

Autor:innen und Institutionen

  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, USA.
  • Medical Scientist Training Program, University of California, San Francisco, CA 94143, USA.
  • Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
  • Joint Graduate Group in Bioengineering, University of California, San Francisco, CA 94720, USA.
  • Department of Nuclear Engineering, University of California, Berkeley, CA 94720, USA.
  • Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA 94143, USA.

ORCID-Profile: Hyunseok Kang, Li Zhang, Chienying Liu, Spencer C Behr, Robert R Flavell

Förderung

  • National Institute of Health and National Cancer Institute

Zitieren

APA

Diwanji, D., Carrodeguas, E., Seo, Y., Kang, H., Soe, M. H., Chiang, J. M., Zhang, L., Liu, C., Behr, S. C., & Flavell, R. R. (2024). Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers. Journal of Clinical Medicine, 13(13), 3963. https://doi.org/10.3390/jcm13133963

Vancouver

Diwanji D, Carrodeguas E, Seo Y, Kang H, Soe MH, Chiang JM, et al. Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers. Journal of Clinical Medicine. 2024;13(13):3963. doi:10.3390/jcm13133963

BibTeX
@article{Diwanji2024,
  author = {Diwanji, Devan and Carrodeguas, Emmanuel and Seo, Youngho and Kang, Hyunseok and Soe, Myat Han and Chiang, Janet M and Zhang, Li and Liu, Chienying and Behr, Spencer C and Flavell, Robert R},
  title = {Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {13},
  pages = {3963},
  doi = {10.3390/jcm13133963}
}
Kostenlos starten →